Vernalis plc is a fragment and structure-based small molecule drug discovery founded in 2018.
Vernalis plc is a company active in the biomedical engineering, pharmaceutical, technology, biology, biotechnology, and engineering industries. The organization is headquartered in Winnersh, United Kingdom and has a presence in Cambridge, Cambridgeshire. Vernalis plc was founded on January 1, 2018 and is currently active.
The company is listed on the Nasdaq and London Stock Exchange. It employs between 50 and 99 workers, with a total number of 65 employees. Vernalis plc has established strategic partnerships with Servier Laboratories.
Fragment and structure-based small molecule drug discovery
Company